Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
…, BJ Verkaik, OJA Figaroa, PJ de Vries, TM Boertien… - Elife, 2021 - elifesciences.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock
TM Boertien, EJW Van Someren… - European journal of …, 2022 - academic.oup.com
Objective Pituitary tumours that compress the optic chiasm are associated with long-term
alterations in sleep–wake rhythm. This may result from damage to intrinsically photosensitive …
alterations in sleep–wake rhythm. This may result from damage to intrinsically photosensitive …
[HTML][HTML] 68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
TM Boertien, J Booij, CBLM Majoie, ML Drent… - european journal of …, 2020 - Springer
Purpose Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to
express somatostatin receptors (SSTR), but results are inconsistent across different studies. …
express somatostatin receptors (SSTR), but results are inconsistent across different studies. …
The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary …
TM Boertien, ML Drent, J Booij, CBLM Majoie… - BMJ open, 2020 - bmjopen.bmj.com
Introduction At present, there is no approved medical treatment option for patients with non-functioning
pituitary adenoma. A number of open-label studies suggest that treatment with …
pituitary adenoma. A number of open-label studies suggest that treatment with …
[HTML][HTML] Protocol: The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning …
TM Boertien, ML Drent, J Booij, CBLM Majoie… - BMJ Open, 2020 - ncbi.nlm.nih.gov
Introduction At present, there is no approved medical treatment option for patients with non-functioning
pituitary adenoma. A number of open-label studies suggest that treatment with …
pituitary adenoma. A number of open-label studies suggest that treatment with …
Novel diagnostic and therapeutic options in pituitary adenoma: An enlightening approach
TM Boertien - 2023 - researchinformation.amsterdamumc …
This thesis addresses several clinical questions regarding pituitary tumours through three
observational studies and an intervention trial. In a prospective study in patients with sellar …
observational studies and an intervention trial. In a prospective study in patients with sellar …
Lanreotide in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): A randomised, double-blind, placebo …
TM Boertien, ML Drent, J Booij… - Endocrine …, 2024 - endocrine-abstracts.org
Background: Patients with non-functioning pituitary macroadenoma (NFMA) currently have
no established medical treatment options. Somatostatin analogues may decrease tumour size…
no established medical treatment options. Somatostatin analogues may decrease tumour size…
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination (preprint)
…, TM Boertien, R Le Grand, MD de Jong, M Prins… - 2021 - pesquisa.bvsalud.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
The galant trial: a randomised placebo-controlled trial in patients with a gallium-68 dotatate pet positive, clinically non-functioning pituitary macroadenoma on the …
TM Boertien, ML Drent, J Booij… - Endocrine …, 2020 - endocrine-abstracts.org
Design: The GALANT study is an investigator-initiated, multicentre, randomised, double-blind,
placebo-controlled trial in adult patients with a suprasellar extending NFMA, either surgery…
placebo-controlled trial in adult patients with a suprasellar extending NFMA, either surgery…
[PDF][PDF] Tessel M Boertien, Madeleine L Drent, 2 Jan Booij, 3 Charles BLM Majoie, 3 Marcel PM Stokkel, 4 Jantien Hoogmoed, 5 Alberto Pereira, 6 Nienke R Biermasz …
PH Bisschop - academia.edu
Introduction At present, there is no approved medical treatment option for patients with non-functioning
pituitary adenoma. A number of open-label studies suggest that treatment with …
pituitary adenoma. A number of open-label studies suggest that treatment with …
